​

Funding Round

Venture Round - ProGene Biomedical

Venture Round - ProGene Biomedical

Investment Firm

Overview

ProGene Biomedical is a clinical reference laboratory specializing in clinical immunology and allergy testing.

Announced Date

Dec 02, 2004

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

N/A

Investor Lead

Ampersand Capital Partners

Ampersand Capital Partners

Ampersand Capital Partners is a debt and early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

Participant Investors

1

Investor Name
Participant InvestorAmpersand Capital Partners

Round Details and Background

ProGene Biomedical raised $5000000 on 2004-12-02 in Venture Round

ProGene Biomedical is a clinical reference laboratory specializing in clinical immunology and allergy testing.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 02, 2004
Venture Round - ProGene Biomedical
1-5.0M

Recent Activity

There is no recent news or activity for this profile.